197 results on '"Shirasaka, Daisuke"'
Search Results
2. A novel fully covered metal stent for unresectable malignant distal biliary obstruction: results of a multicenter prospective study.
3. Observation of gastro-esophageal reflux by MRI: a feasibility study
4. Relationship of BRAF mutation, morphology, and apoptosis in early colorectal cancer
5. Diagnostic significance of gently sloping depression and irregular margin in superficial elevated colorectal tumors
6. Excessive alcohol intake enhances the development of synchronous cancerous lesion in colorectal cancer patients
7. MDR1 Genotype-Related Duodenal Absorption Rate of Digoxin in Healthy Japanese Subjects
8. Analysis of Helicobacter pylori vacA Gene and Serum Antibodies to VacA in Japan
9. METALLOTHIONEIN AND COLORECTAL TUMORS
10. SUPERFICIALLY ELEVATED-TYPE SERRATED HYPERPLASTIC LESION OF THE STOMACH WITH MINUTE ADENOCARCINOMA
11. Role of metallothionein in Helicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy
12. Helicobacter pylori VacA and Gastric Ulcer
13. Acute gastric anisakiasis: 28 Cases during the last 10 years
14. Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in Japan
15. Impact of Helicobacter pylori Eradication Therapy on Histologic Change in the Distal Esophagus
16. Effects of Helicobacter pylori eradication therapy on gastric emptying measured using the 13C-octanoic acid breath test and the acetaminophen method
17. HLA-DQB1 locus and gastric cancer in Helicobacter pylori infection
18. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: Its clinical efficacy and adverse effects compared with those of conventional steroid therapy
19. COVERED WALLSTENT FOR PALLIATION OF MALIGNANT COMMON BILE DUCT STRICTURE: PROSPECTIVE MULTICENTER EVALUATION
20. Inhibitory Effects of Polyphenols on Gastric Injury by Helicobacter pylori VacA Toxin
21. Helicobacter pylori VacA Activates the p38/Activating Transcription Factor 2-mediated Signal Pathway in AZ-521 Cells
22. PROSPECT OF ENDOSCOPIC MUCOSAL RESECTION FOR EARLY GASTRIC CANCER: OUR DEVICES IN INSULATED-TIP ELECTROSURGICAL KNIFE METHOD
23. Relationship Between Gastric Ulcer and Helicobacter pylori VacA Detected in Gastric Juice Using Bead-ELISA Method
24. Effect of Helicobacter pylori-Induced Cyclooxygenase-2 on Gastric Epithelial Cell Kinetics: Implication for Gastric Carcinogenesis
25. ARGON PLASMA COAGULATION FOR TREATMENT OF HEMORRHAGIC RADIATION GASTRODUODENITIS
26. Report from Kinki Chapter Educational Seminar: Gastrointestinal Knowledge Required for Physicians.
27. Application of Bead-ELISA method to detectHelicobacter pyloriVacA
28. Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.
29. Cronkhite-Canada syndrome presenting as recurrent severe acute pancreatitis
30. Effectiveness of Measures Against Influenza Outbreak at A Refuge Center After The Touhoku-Pacific Ocean Earthquake
31. Role of metallothionein inHelicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy
32. M1067 In Vitro Activityies of Levofloxacin and Seven Other Fluorquinolones Against Clinical Isolates of Helicobacter pylori with or Without gYRA Mutations; What Regimen Is a Promising Eradication Therapy in the Next Generation?
33. Relationship of BRAF mutation, morphology, and apoptosis in early colorectal cancer
34. Can Polaprezinc Be Attributed To Reduce the Risk of Gastric Carcinogenesis in Helicobacter pylori-Positive Young People?
35. Helicobacter pylori VacA Enhances Prostaglandin E 2 Production through Induction of Cyclooxygenase 2 Expression via a p38 Mitogen-Activated Protein Kinase/Activating Transcription Factor 2 Cascade in AZ-521 Cells
36. Observation of gastro-esophageal reflux by MRI: a feasibility study
37. Favorable Genetic Polymorphisms Predictive of Clinical Outcome of Chemoradiotherapy for Stage II/III Esophageal Squamous Cell Carcinoma in Japanese
38. Primary Levofloxacin-Resistance and gyrA/B Mutations among Helicobacter pylori in Japan
39. Clinical Role of gyrA Mutations in Levofloxacin-Based Rescue Therapy for Helicobacter pylori Infection in Japan
40. Which Is the Key To Predict the Treatment Response to Definitive Chemoradiotherapy for Esophageal Cancer by Routine Endoscopy, Timing, Biopsy or Endoscopic Findings?
41. Diagnostic significance of gently sloping depression and irregular margin in superficial elevated colorectal tumors
42. TREATMENT RESULTS OF GLOTTIC AND HYPOPHARYNGEAL CANCERS-FROM THE VIEWPOINT OF HEAD AND NECK SURGEON-
43. The Role of Metallothionein in Helicobacter pylori Positive Gastric Mucosa with or without Early Gastric Cancer and the Effect on Its Expression after Eradication Therapy
44. Histological Changes of Lower Esophagus Transiently Occur One Month after Helicobacter pylori Eradication, but Will Recover within 12 Months
45. Circadian Variability of Pharmacokinetics of 5-Fluorouracil and CLOCK T3111C Genetic Polymorphism in Patients With Esophageal Carcinoma
46. Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection
47. Prevention of Irinotecan-Induced Diarrhea by Oral Sodium Bicarbonate and Influence on Pharmacokinetics
48. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori
49. Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan
50. at the 44th Annual Meeting of the Japanese Smooth Muscle Society
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.